How the wire works

Peptide Wire is an automated news desk for one subject: therapeutic peptides. It watches public feeds and databases through the day, keeps only the items that concern peptides, GLP-1 drugs, compounding or the companies and agencies around them, and files each one as a short wire entry.

Each entry carries a rewritten headline, a one-line dek and three bullets: what happened, why it matters, and what comes next. The bullets are drawn only from the source text. Every entry links to the original article, study record or press release, and that link is the record.

Trial registrations come from ClinicalTrials.gov and papers from PubMed. Trade coverage comes from Fierce Biotech, STAT, BioPharma Dive, Drugs.com, Google News. Market quotes are delayed.

Nothing published here is medical advice, and inclusion of a product, pharmacy or company is not an endorsement.